JERALD P RADICH, MD
Osteopathic Medicine at Pacific St, Seattle, WA
License number
Washington MD00021791
Category
Osteopathic Medicine
Type
Medical Oncology
Address
Address
1959 NE Pacific St, Seattle, WA 98195
Phone
(206) 288-1000
(206) 543-6420
(206) 543-6420
Personal information
See more information about JERALD P RADICH at radaris.comName
Address
Phone
26327 SE 33Rd St, Issaquah, WA 98075
Issaquah, WA
26327 33Rd St, Sammamish, WA 98075
26327 33Rd St, Issaquah, WA 98075
26327 33Rd, Suquamish, WA 98075
Organization information
See more information about JERALD P RADICH at bizstanding.comJerald P Radich MD
1100 Fairview Ave N #D3-100, Seattle, WA 98109
Categories:
Oncology Physicians & Surgeons
Phone:
(206) 667-5000 (Phone)
Professional information
Jerald Patrick Radich, Seattle WA
Specialties:
Internal Medicine, Medical Oncology, Hematology & Oncology, Radiation Oncology
Work:
Seattle Cancer Alliance Outpatient Ambulatory
825 Eastlake Ave E, Seattle, WA 98109 University of Washington Medical Center
1959 NE Pacific St, Seattle, WA 98195
825 Eastlake Ave E, Seattle, WA 98109 University of Washington Medical Center
1959 NE Pacific St, Seattle, WA 98195
Education:
University of California at Davis (1983)
Dr. Jerald P Radich, Seattle WA - MD (Doctor of Medicine)
Specialties:
Oncology, Medical Oncology
Address:
Fred Hutchinson Cncr Rsrch Ctr
1100 Fairview Ave N SUITE D3-100, Seattle 98109
(206) 667-5000 (Phone)
1100 Fairview Ave N SUITE D3-100, Seattle 98109
(206) 667-5000 (Phone)
Certifications:
Internal Medicine, 1986, Medical Oncology, 1989
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
Fred Hutchinson Cncr Rsrch Ctr
1100 Fairview Ave N SUITE D3-100, Seattle 98109
University of Washington Medical Center
1959 East Pacific St, Seattle 98195
1100 Fairview Ave N SUITE D3-100, Seattle 98109
University of Washington Medical Center
1959 East Pacific St, Seattle 98195
Education:
Medical School
University of California At Irvine / California College of Medicine & Surgery
Graduated: 1983
University Of Washington
University of California At Irvine / California College of Medicine & Surgery
Graduated: 1983
University Of Washington
Jerald P Radich, Seattle WA
Specialties:
Oncologist
Address:
1100 Fairview Ave N, Seattle, WA 98109
1959 Ne Pacific St, Seattle, WA 98195
1959 Ne Pacific St, Seattle, WA 98195
Education:
University of California Davis, School of Medicine - Doctor of Medicine
University of Washington Medical Center - Fellowship - Oncology (Internal Medicine)
University of Washington Medical Center - Residency - Internal Medicine
University of Washington Medical Center - Fellowship - Oncology (Internal Medicine)
University of Washington Medical Center - Residency - Internal Medicine
Board certifications:
American Board of Internal Medicine Certification in Internal Medicine, American Board of Internal Medicine Sub-certificate in Oncology (Internal Medicine)
Gene Signatures For Prediction Of Therapy-Related Myelodysplasia And Methods For Identification Of Patients At Risk For Development Of The Same
US Patent:
2013027, Oct 17, 2013
Filed:
Jun 7, 2013
Appl. No.:
13/913077
Inventors:
Stephen Forman - Duarte CA, US
Jerald P. Radich - Seattle WA, US
Liang Li - Duarte CA, US
Min Li - Duarte CA, US
Lue Ping Zhao - Seattle WA, US
Jerald P. Radich - Seattle WA, US
Liang Li - Duarte CA, US
Min Li - Duarte CA, US
Lue Ping Zhao - Seattle WA, US
International Classification:
C12Q 1/68
US Classification:
506 9, 506 16
Abstract:
In one embodiment, a gene expression signature for predicting risk of developing therapy-related myelodysplasia or acute myeloid leukemia (t-MDS/AML) after autologous hematopoietic cell transplantation (aHCT) is provided. In another embodiment, a method for predicting a risk for development of t-MDS/AML after aHCT is provided. Such a method may include providing a biological sample that contains CD34 cells from a subject; detecting a test expression level of a set of two or more genes of a gene expression signature; comparing the test expression level of a set of corresponding training expression levels that include a training case expression level and a training control expression level; and predicting a high risk of developing t-MDS/AML when the test expression level is at or about the training case expression level or predicting a low risk of developing t-MDS/AML when the test expression level is at or about the training control expression level.